Amerigen's Generic Fesoterodine Fumarate Receives Approval in the U.S.
Company completes previously announced equity financing of $42.5 million concurrently with the closing of the merger
Amerigen pharma's Generic Ranolazine Receives Approval in US
Enforcement Report - Week of January 2, 2019
Amerigen Pharms` Generic Amphetamine Aspartate;Amphetamine Sulfate;Dextroamphetamine Saccharate;Dextroamphetamine Sulfate Receives Tentative Approval in US
Enforcement Report - Week of October 24, 2018
Amerigen Pharma Ltd's Generic Miglustat Receives FDA Approval
Amerigen Pharma`s Generic Miglustat Receives Approval In US
Amerigen Pharma`s Generic Cyclophosphamide Receives Approval In US